In summary, our results suggest that exosomal miR-197-3p can regulate the AKT/mTOR pathway, affecting the progression of NPC, and can target HSPA5 to inhibit autophagy and improve the radiotherapy sensitivity of NPC (Figure 9). The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.